We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 27 Jul 2015
Print article
Image: The Altair 240 clinical chemistry analyzer (Photo courtesy of EKF Diagnostics).
Image: The Altair 240 clinical chemistry analyzer (Photo courtesy of EKF Diagnostics).
Image: The Stanbio Chemistry GSP LiquiColor Assay analyzer (Photo courtesy of EKF Diagnostics).
Image: The Stanbio Chemistry GSP LiquiColor Assay analyzer (Photo courtesy of EKF Diagnostics).
Clinical chemistry, both instrumentation and reagents, was the focus of presentations at booth 1018 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

EKF Diagnostics (Cardiff, United Kingdom), a global in vitro diagnostics company, took advantage of the AACC Annual Meeting to launch the Altair 240 clinical chemistry analyzer.

This new bench-top platform represents EKF Diagnostics’ first fully integrated chemistry system designed for the global market. EKF believes that the new Altair 240 clinical chemistry analyzer fulfills an international market need for a fully automated bench-top platform supported by the reliable Stanbio Chemistry (Boerne, TX, USA) reagent menu.

“We listened to the needs of our customers and designed the Altair 240 to be easy to learn, operate, and maintain,” said Albert Blanco, business unit director at EKF Diagnostics. “Because it runs on Windows 7, operators can easily navigate its intuitive, touch screen menu. Features such as the capability to use bar coded, primary sample tubes, auto-rerun, auto-dilution and STAT interruption—all function to maximize the system’s overall efficiency.”

EKF will also use the AACC Annual Meeting venue to discuss the latest additions to its Stanbio clinical chemistry range. This range includes a large selection of clinical chemistry assays, controls, and calibrators, which are fully compatible with most major brand open channel chemistry analyzers.

A notable addition to the reagent menu is the Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor test; a new diabetes biomarker test that provides a two to three week indicator of average blood glucose. The GSP LiquiColor test is based on a double enzymatic degradation method that utilizes the specificity of fructosyl-amino oxidase to eliminate inaccuracies caused by non-glycated protein reducing substances, which significantly interfere with the NBT fructosamine method. The test is available as a liquid-stable kit with calibrator. It is suitable for use on a variety of clinical chemistry analyzers, with on-board stability of up to four weeks.

Other instruments to be highlighted at the AACC Annual Meeting include the DiaSpect and HemoPoint H2. DiaSpect is a hand held device touted as being the world’s fastest hemoglobin measurement system. The instrument is described as offering laboratory quality performance for anemia screening in all climatic conditions in less than two seconds. The HemoPoint H2 stores over 4000 patient results and is designed for use in blood banks, clinics, and hospitals. This instrument provides immediate and simultaneous high quality results for both hemoglobin and hematocrit.

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
EKF Diagnostics
Stanbio Chemistry


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.